Skip to main content
Clinical Trials/JPRN-UMIN000000963
JPRN-UMIN000000963
Completed
未知

Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndrome - Cyclosporine for MCNS

Yoshihiko Saito0 sites30 target enrollmentJanuary 1, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Minimal change nephrotic syndrome
Sponsor
Yoshihiko Saito
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 1, 2010
End Date
October 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yoshihiko Saito

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Cr\>\=2\.0mg/dl or eGFR\<50 Malignancy Uncontrolled hypertension Seizure disorder Pregnant women Infection Severe cardiac, hepatic or pancreatic disease Alelrgy to cyclosporine

Outcomes

Primary Outcomes

Not specified

Similar Trials